Drugs / Dermacyn
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06873646 | Nov 2025 → Jun 2026 overdue | ulcer of lower limbs | Mohd Khairul Zul Hasymi Firdaus | Not yet recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00516958 Comparator | May → Dec 2007 | ulcer of lower limbs | Oculus Innovative Sciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dermacyn | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06873646 ↗ |
| Route | Topical | “Topical Dermacyn once a day and levofloxacin 750 mg PO per day; both for 10 days” NCT00516958 ↗ |